AfriCultuReS – Enhancing Food Security in AFRIcan AgriCULTUral Systems with the Support of REmote Sensing - aims to design, implement and demonstrate an integrated agricultural monitoring and early warning system that will support decision making in the field of food security. AfriCultuReS will deliver a broad range of climatic, production, biophysical and economic information, for various regions in Africa.

EU Horizon 2020 Research and Innovation programme.

The project coordinator: GMV AEROSPACE AND DEFENCE SA (Spain). Other partners from EU Members are: - ARISTOTELIO PANEPISTIMIO THESSALONIKIS (Greece); - DRAXIS ENVIRONMENTAL S.A. (Greece); - NOORT HARMANNUS, CONRADUS PIETER (Pays-Bas); - UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA (Italie); - SVERIGES METEOROLOGISKA OCH HYDROLOGISKA INSTITUT (Suède) - UNIVERSIDAD DE CANTABRIA (Espagne); - UNIVERSITY OF LEEDS (Royaume-Uni) ; - THE UNIVERSITY OF SHEFFIELD (Royaume-Uni) ; Other non-EU Members involved in the project are: - CENTRE FOR REMOTE SENSING AND GEOGRAPHIC INFORMATION SERVICES LBG (Ghana); - LOCATE IT LIMITED (Kenya); - OBSERVATOIRE DU SAHARA ET DU SAHEL (Tunisie); - SOUTH AFRICA NATIONAL SPACE AGENCY (Afrique du Sud) ; Responsible partner from LDC: - CENTRE REGIONAL AGRHYMET (Niger); - UNIVERSIDADE EDUARDO MONDLANE (Mozambique); - GEOSAS CONSULTING SERVICE PLC (Éthiopie); - UNIVERSITY OF RWANDA (Rwanda).

CENTRE REGIONAL AGRHYMET (Niger); - UNIVERSIDADE EDUARDO MONDLANE (Mozambique); - GEOSAS CONSULTING SERVICE PLC (Éthiopie); - UNIVERSITY OF RWANDA (Rwanda).

The research will strengthen user's operational capability in agricultural areas management activities, reducing costs and increasing performance by: - accessing relevant online services and integrating innovative R&D products, previously tested by end user organizations, into their own decision making chain; - acquiring more updated and accurate information which may improve their preparedness level and operational efficiency; - obtaining information on crop & livestock status in a reliable, transparent and fast way, increasing trans-national cooperation between users who can share the same information.

Project Requested EC Contribution: EUR 8,531,533,20 Total requested EC Contribution for LDC countries: EUR 1,190,320 of which: - CENTRE REGIONAL AGRHYMET (Niger): EUR 494,132.50 - UNIVERSIDADE EDUARDO MONDLANE (Mozambique): EUR 140,812.50 - GEOSAS CONSULTING SERVICE PLC (Éthiopie): EUR 387,500 - UNIVERSITY OF RWANDA (Rwanda): EUR 167,875.

Crop yield and biomass prediction models will be enhanced through the fusion of EO data and climate models, emphasizing the use of the complementary sensors of the EU Sentinels constellation.

The project will: - produce a web tool that supports early decision-making for the stakeholders of African food production; - increased involvement of citizens and stakeholders in food production and food supply chain management in Africa, taking into account the gender dimension and women's role in food production and supply; - improve participation of African organisations in GEO and Copernicus (GMES & Africa initiative); - foster cooperation with initiatives developing the Global Framework for Climate Services (GFCS) in African countries; - contribute to implementing the SDGs, in particular SDG 2 'End hunger, achieve food security and improved nutrition and promote sustainable agriculture' and SDG 13 'Take urgent action to combat climate change and its impacts'; - provide a strong Earth observation building blocks for an EU-Africa Research and Innovation Partnership focusing on food and nutrition security and sustainable agriculture; - contribute to independent and neutral evaluation of agricultural production in Africa; - improve decision making capacity regarding food supply and management in Africa; - move projection of food supply and agricultural risk assessment at the level of the African continent beyond the current capability.

Current or in progress

1 November 2017 to 31 October 2021.

https://cordis.europa.eu/project/id/774652

GMV AEROSPACE AND DEFENCE SA, Calle Isaac Newton Parque Tecnológico De Madrid, 28760 Tres Cantos. Contact point reachable via Cordis page https://cordis.europa.eu/project/id/774652

The E-SHAPE proposal is driven by the need to develop operational EO services with and for the users and to create a conducive environment whereby the strengths of Europe are exploited towards addressing societal challenges, fostering entrepreneurship and supporting sustainable development. The proposal objectives are 1) to develop operational EO services with and for users active in key societal sectors; 2) to demonstrate the benefits of the EO pilots through the coordinated downstream exploitation of EO data and the utilization of existing EO resources; 3) to promote the uptake of pilots at national and international scale, across vertical markets (private and public) and amongst key user communities; 4) to enable the long-term sustainability of the numerous pilots, their penetration in public and private markets and support their upscaling; 5) to increase uptake by raising awareness on the solutions developed through tailored and well-targeted communication, dissemination and outreach activities. The proposal aims at setting-up and promoting a sustainable organization dedicated to users' uptake of European EO resources, building on Copernicus and GEOSS through the development of co-design pilots (i.e. application-oriented products, services or solutions) built on a user-centric approach and delivering economic, social and policy value to European citizens. It has also the ambition through the development of 27 pilots organized in seven showcases to deliver information that will also contribute to the three GEO engagements (SDGs, Paris Agreement and Sendai Framework).

EU Horizon 2020 Research and Innovation programme.

The project coordinator: ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS (France) Other partners from EU Members are: - ACADEMY OF ATHENS (Greece); - ASSOCIATION EUROPEENNE EURISY (France); - CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (France); - CENTRO DE INVESTIGACIÓN ECOLÓGICA Y APLICACIONES FORESTALES (Spain); - COLLECTE LOCALISATION SATELLITES (France); - CONSIGLIO NAZIONALE DELLE RICERCHE (Italy); - Centro Internazionale in Monitoraggio Ambientale - Fondazione CIMA (Italy); - DANMARKS TEKNISKE UNIVERSITET (Denmark); - DEIMOS SPACE SOCIEDAD LIMITADA UNIPERSONAL (Spain); - DEUTSCHER WETTERDIENST (Germany); - DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV (Germany) - DIABALKANIKO KENTRO PERIBALLONTOS (Greece); - DRAXIS ENVIRONMENTAL S.A. (Greece); - ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (Greece); - EUROPEAN ASSOCIATION OF REMOTE SENSING COMPANIES (Belgium); - EUROPEAN UNION SATELLITE CENTRE (Spain); - EVENFLOW (Belgium); - EUR GeoSurveys - EGS (Belgium); - FONDAZIONE CENTRO EUR -MEDITERRANEOSUI CAMBIAMENTI CLIMATICI (Italy); - HELMHOLTZ-ZENTRUM FUR UMWELTFORSCHUNG GMBH - UFZ (Germany); - HELMHOLTZ-ZENTRUM GEESTHACHT ZENTRUM FUR MATERIAL- UND KUSTENFORSCHUNG GMBH (Germany); - HELSINGIN YLIOPISTO (Finland); - ILMATIETEEN LAITOS (Finland); - INSTITUTO PORTUGUES DO MAR E DA ATMOSFERA IP (Portugal); - INTEGRATED CARBON OBSERVATION SYSTEM EUROPEAN RESEARCH INFRASTRUCTURECONSORTIUM (Finland); - INTERNATIONALES INSTITUT FUER ANGEWANDTE SYSTEMANALYSE (Austria); - ISTITUTO NAZIONALE DI GEOFISICA E VULCANOLOGIA (Italy); - LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (Luxembourg); - MARIENE INFORMATIE SERVICE MARIS BV (Netherlands); - MARTIN-LUTHER-UNIVERSITAET HALLE-WITTENBERG (Germany); - Masarykova univerzita (Czech Republic); - NATIONAL OBSERVATORY OF ATHENS (Greece); - NEUR PUBLIC AE PLIROFORIKIS & EPIKOINONION (Greece); - OPEN GEOSPATIAL CONSORTIUM (EUROPE) LIMITED LBG (United Kingdom); - PLANETEK ITALIA SRL (Italy); - PLYMOUTH MARINE LABORATORY (United Kingdom); - STICHTING DELTARES (Netherlands); - STICHTING WAGENINGEN RESEARCH (Netherlands); - SUOMEN YMPARISTOKESKUS (Finland); - SVERIGES METEOROLOGISKA OCH HYDROLOGISKA INSTITUT (Sweden); - TRANSVALOR S.A. (France); - UMWELTBUNDESAMT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (UBA GMBH) (Austria); - UNIVERSITA DELLA CALABRIA (Italy); - UNIVERSITAET BAYREUTH (Germany); - UNIVERSITEIT TWENTE (Netherlands); - VEDURSTOFA ISLANDS (Iceland); - VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V. (Belgium); - ZENTRALANSTALT FUR METEOROLOGIE UND GEODYNAMIK (Austria) Other non-EU Members involved in the project are: - SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS (Switzerland); - TEL AVIV UNIVERSITY (Israel); Responsible partner from LDC: - MEKELLE UNIVERSITY (Ethiopia).

- MEKELLE UNIVERSITY (Ethiopia) End-user: KIFIYA, ATA, IFAD, MoA, MoF, State Banks, Public Finance Enterprise Agency, Insurance companies, Farmers.

The research will: - Provide a financial service delivery to smallholder farmers in Ethiopia with a geodata-driven risk-mitigation (insurance) product that offers a basic safety net to protect them against weather related perils. The provision of the service will be supported by on-site training, eSupport to create a long-duration product sustainability and a country-specific independence in knowledge and skills.

Overall budget: EUR 15,772,89.84. Maximum EU Grant Amount: EUR 14,998,976.27. Total requested EC Contribution for LDC country (Ethiopia): EUR 51,812.50 of which: - MEKELLE UNIVERSITY (Ethiopia): EUR 51,812.50.

Vegetation-Index Crop-Insurance.

The project will: - Assist farmers with actionable advises, - Support farmers to CAP conformance, - Mapping Crop type and monitor CAP's Greening obligations, - Identify Crop through the use and fusion of EO, in-situ and crowd sources data.

Current or in progress

1 May 2019 until 30 April 2023.

https://www.armines.net/fr

ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS, Boulevard Saint Michel 60, 75272 Paris, France. Contact point reachable via cordis page https://cordis.europa.eu/project/id/820852

MONOCLE innovates and develops sensor, platform, and data handling technologies to increase coverage and lower the cost of in situ sensors in inland and coastal water bodies. These ecosystems are particularly vulnerable to direct anthropogenic impacts but of high economic importance and crucial to sustainable food, energy, and clean water supply. At the same time, these water bodies represent areas of the weakest performance in present EO capability to date.

EU Horizon 2020 Research and Innovation programme.

The project coordinator: PLYMOUTH MARINE LABORATORY (United Kingdom). Other partners from EU Members are: - PEAK DESIGN LIMITED (United Kingdom); - INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU GEOLOGIE SI GEOECOLOGIE MARINAGEOECOMAR (Romania); - SCHMIDT NORBERT CARL (Netherlands); - DRONEGRID (Belgium); - CONSERVATION EDUCATION AND RESEARCH TRUST (United Kingdom); - AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (Spain); - WATER INSIGHT BV (Netherlands); - THE UNIVERSITY OF STIRLING (United Kingdom); - UNIVERSITEIT LEIDEN (Netherlands); - VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V. (Belgium) Responsible partner from LDC: - TANZANIA FISHERIES RESEARCH INSTITUTE (Tanzania)

- TANZANIA FISHERIES RESEARCH INSTITUTE (Tanzania).

The research will: - will reduce uncertainties in Earth Observation (EO) by characterising atmospheric and water optical properties. - will deploy new and improved sensors on autonomous platforms (buoys, ships, drones), and further fill information gaps by developing low-cost complementary solutions for citizen scientists. - provide essential reference observations needed to further improve and grow EO-based water quality services.

Project Requested EC Contribution: EUR 4,999,862.50. Total requested EC Contribution for LDC country (Tanzania): EUR 119,125 of which: - TANZANIA FISHERIES RESEARCH INSTITUTE (Tanzania): EUR 119,125.

The campaign will focus on biological water quality issues.

The project will - demonstrate the added value of EO and water quality oriented sensor network to Copernicus EO services, GEOSS data brokering and GEO capacity building initiatives through a number of validation campaigns and use cases, including data-poor regions where no similar infrastructure yet exists. - provide information necessary to ensure food, water and energy security, to cope with the scarcity of natural resources, to develop mitigation and adaptation solutions to climate change, and to make communities more resilient to natural hazards. - Lower technology and computing requirement for innovators and consultants.

Current or in progress

1 February 2018 until 31 July 2022.

https://www.pml.ac.uk/

PLYMOUTH MARINE LABORATORY, Prospect Place, The Hoe, Pl1 3dh Plymouth, United Kingdom. Contact point reachable via Cordis page https://cordis.europa.eu/project/id/776480

Sustainable management of human activities affecting Atlantic marine ecosystems is critical to maintain its health and to support the blue economy of the bordering countries. TRIATLAS will contribute to this by delivering knowledge of the current state and future changes of the Atlantic marine ecosystems. We achieve this through a basin-wide approach integrating research from the North and South, that closes critical knowledge gaps in the Tropical and South Atlantic which impede an understanding of the entire basin. We bring together an interdisciplinary team of marine ecologists, physical oceanographers, climate researchers, and social scientists from 34 different institutions in Europe, Africa, and South America, together with multisectoral and regional stakeholders. We will enhance knowledge of the marine ecosystems in key areas of the Atlantic using existing and pivotal new (physical, biological, societal) observations. Earth system, ecological, and socio-economic models and observations will be used to assess the cumulative impacts of (climatic, pollution, and fishing) pressures driving fluctuations in the marine ecosystem, and the potential for tipping point behaviour and regime shifts. We will develop the first predictions of the marine-ecosystem for the next 40 years for the whole Atlantic, by combining state-of-the-art climate prediction and ecosystem models, with Shared Socioeconomic Pathways, and by conducting socioeconomic vulnerability assessments services, with stakeholder engagement. TRIATLAS will enhance capacity in marine ecosystems, oceanography, and climate research in countries bordering the South and Tropical Atlantic Ocean. There will be close cooperation and alignment with relevant European Commission services and the South-South Framework for Scientific and Technical Cooperation, as well as other relevant initiatives in the field. We will contribute to upscale cooperation around the Atlantic.

EU Horizon 2020 Research and Innovation Programme.

The project coordinator: UNIVERSITETET I BERGEN, Norway Other partners from EU Members are: - HELMHOLTZ ZENTRUM FUR OZEANFORSCHUNG KIEL, Germany - JOHANN HEINRICH VON THUENEN-INSTITUT, BUNDESFORSCHUNGSINSTITUT FUER LAENDLICHE RAEUME, WALD UND FISCHEREI , Germany - LEIBNIZ-ZENTRUM FUER MARINE TROPENFORSCHUNG (ZMT) GMBH, Germany - CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL, Germany - METEO-France, France - CENTRE EUROPEEN DE RECHERCHE ET DE FORMATION AVANCEE EN CALCUL SCIENTIFIQUE, France - INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT, France - CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS, France - UNIVERSITE PAUL SABATIER TOULOUSE III, France - BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACIÓN, Spain - UNIVERSIDAD COMPLUTENSE DE MADRID, Spain - SORBONNE UNIVERSITE, France - AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS, Spain - ECOLE NORMALE SUPERIEURE, France - NATIONAL UNIVERSITY OF IRELAND GALWAY, Ireland - UNITED KINGDOM RESEARCH AND INNOVATION, United Kingdom - UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA, Spain - UNIVERSIDAD DE VIGO, Spain Other partners from non-EU countries are: - UNIVERSITY OF CAPE TOWN, South Africa - INSTITUTO NACIONAL DE DESENVOLVIMENTO DAS PESCAS, Cape Verde - HAVFORSKNINGSINSTITUTTET, Norway - STIFTELSEN NANSEN SENTER FOR MILJOOG FJERNMALING, Norway - INSTITUTO NACIONAL DE INVESTIGACAO PESQUEIRA, Angola - UNIVERSITE FELIX HOUPHOUET BOIGNY, Cote d'Ivoire - CENTRE DE RECHERCHES OCEANOLOGIQUES, Cote d'Ivoire - UNIVERSIDADE FEDERAL DO RIO GRANDE-FURG, Brazil - UNIVERSIDADE FEDERAL DE PERNAMBUCO, Brazil - UNIVERSIDADE FEDERAL DE SANTA CATARINA, Brazil - UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO, Brazil - NORCE NORWEGIAN RESEARCH CENTRE AS, Norway - UNIVERSIDADE DE CABO VERDE, Cape Verde - UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE, Brazil - UNIVERSITY OF NAMIBIA, Namibia.

Benin: - UNIVERSITE D'ABOMEY-CALAVI Senegal : - INSTITUT SENEGALAIS DE RECHERCHES AGRICOLES.

Project requested EC contribution: EUR 11 074 400.

Natural sciences

Current or in progress

From 1 June 2019 to 31 May 2023.

https://triatlas.w.uib.no/

Contact point reachable via Cordis page https://cordis.europa.eu/project/id/817578

SoNAR-Global is a global consortium led by social scientists specializing in emerging infectious diseases (EID) and antimicrobial resistance (AMR). It will build a sustainable international social science network to engage the active participation of social sciences and promote complementarity and synergy in the governance of prevention and response to infectious threats and AMR. As such, it will become an integral part of emergency response. Partnering with major international and regional institutions, it will lead activities through a program that builds governance from the ground up. It will: Develop an open-access platform to support the SoNAR-Global activities and to share them broadly. Adapt, test, and evaluate vulnerability assessment tools on the ground and engagement models to facilitate collaboration across multiple stakeholders. Create, pilot, and evaluate curricula for training social scientists in preparedness and response to infectious threats and through curricular development and piloting social science knowledge of infectious threats among non-social sciences actors.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

SoNAR-Global Consortium (Grant agreement 825671).

BRAC UNIVERSITY, Bangladesh.

Grant for research and innovation.

EUR 260,738.75 (for the whole duration of the project).

Governance and other challenges in the preparedness for and the response to infectious threats

Improved health conditions.

Current or in progress

Three-years (since 1 January 2019).

https://www.sonar-global.eu/

Coordinator INSTITUT PASTEUR, France. https://cordis.europa.eu/project/id/825671

Although vaccination is an effective way to reduce the huge disease burden associated with diarrhoea caused by enteric pathogens, many attempts to develop vaccines for shigellosis and ETEC infections have failed and a number of current approaches are too complex and costly to provide an adequate solution for LMICs. This Consortium is dedicated to advancing a radically new approach against Shigella and ETEC based not on the immunodominant, but highly variable Shigella LPS O-antigen, target of almost all past and current vaccine development efforts. There are four pillars on which the ShigETEC vaccine has been designed: (i) Elimination of the LPS O-antigen to allow recognition of multiple antigens on the cell surface that are shared among different serotypes of Shigella and are increasingly being recognized as important in protection from shigellosis. These antigens are also closely related to those of ETEC and may also help in protecting against that pathogen as well. (ii) Elimination of the invasiveness of Shigella by disruption of the invasion complex resulting in a much safer/less reactogenic oral vaccine that can take advantage of gut mucosal immunity, possibly allowing administration of high vaccine doses and therefore addresses the low immunogenicity seen with other live attenuated vaccine candidates. (iii) Addition of detoxified toxin antigens of ETEC that will induce neutralizing/blocking antibodies to these critical virulence factors. (iv) Rational molecular design of ShigETEC will allow future generations of vaccines to include additional antigens for other pathogens. The work programme entails manufacture of clinical trial material, first-in-human testing for safety and immunogenicity in non-endemic adults, a sero-epidemiology study to learn about natural immune response to the vaccine, and importantly testing the vaccine in endemic populations. The Consortium comprises partners from EU and Bangladesh that bring along highly complementary expertise.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium SHIGETECVAX (Grant agreement 815568).

INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH, Bangladesh.

EUR 1,924,713.27 (for the whole duration of the project).

Health research and innovation.

Improved health conditions.

Current or in progress

Five-years (since 1 September 2019).

Coordinator EUROPEAN VACCINE INITIATIVE EWIV, Germany. Contact point reachable via Cordis page https://cordis.europa.eu/project/id/815568

Schistosomiasis is a poverty-related neglected tropical disease, impacting one billion people in 74 countries. Science ranked a schistosomiasis-vaccine as one of the top-10 vaccines urgently needed. Chemotherapy is the preferred method for schistosomiasis control; but the effectiveness of mass-treatment programs is compromised by reinfection requiring regular re-treatment. An efficacious vaccine, with long-lasting protection against all schistosomiasis forms, would impact disease control. We request funding for the clinical development of our SchistoShield®-vaccine (Sm- p80 antigen+GLA-SE adjuvant) in Burkina Faso and Madagascar, where Schistosoma mansoni (causing intestinal/ hepatic schistosomiasis) and S. haematobium (causing urinary schistosomiasis) are endemic. In baboon studies, SchistoShield® has been effective against all major schistosome species. It is the only vaccine candidate having consistently exhibited potent prophylactic, anti-fecundity, egg-induced pathology resolving, transmission-blocking and therapeutic efficacy. The objectives are to 1) assess the safety/immunogenicity of SchistoShield® in a Phase I clinical study in healthy adults from Africa; 2) refine and develop a female worm schistosome human challenge model; 3) identify correlates of protection, innate and adaptive immune signatures, gene expression and the role of antibodies in the prevention/control of Schistosoma infections; and 4) foster a global consortium to advance research on schistosomiasis disease burden, vaccines and address downstream access constraints in resource-poor settings. The funding requested will allow the clinical development of SchistoShield®. African site research capacity will be improved and epidemiological burden data using novel diagnostic techniques will be used to advance clinical development to Phase 2 and potential future elimination project

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium VASA (Grant agreement 815643).

GROUPE DE RECHERCHE ACTION EN SANTE SARL, Burkina Faso.

Grant for research and innovation.

EUR 643,812.51 (for the whole duration of the project).

Health research and innovation.

Improved health conditions.

Current or in progress

Five years (since 1 June 2019).

https://cordis.europa.eu/project/rcn/223199/factsheet/en

Coordinator THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE, UK. Contact point reachable via cordis pagehttps://cordis.europa.eu/project/id/815643

Schistosomiasis is a poverty-related neglected tropical disease, impacting one billion people in 74 countries. Science ranked a schistosomiasis-vaccine as one of the top-10 vaccines urgently needed. Chemotherapy is the preferred method for schistosomiasis control; but the effectiveness of mass-treatment programs is compromised by reinfection requiring regular re-treatment. An efficacious vaccine, with long-lasting protection against all schistosomiasis forms, would impact disease control. We request funding for the clinical development of our SchistoShield®-vaccine (Sm- p80 antigen+GLA-SE adjuvant) in Burkina Faso and Madagascar, where Schistosoma mansoni (causing intestinal/ hepatic schistosomiasis) and S. haematobium (causing urinary schistosomiasis) are endemic. In baboon studies, SchistoShield® has been effective against all major schistosome species. It is the only vaccine candidate having consistently exhibited potent prophylactic, anti-fecundity, egg-induced pathology resolving, transmission-blocking and therapeutic efficacy. The objectives are to 1) assess the safety/immunogenicity of SchistoShield® in a Phase I clinical study in healthy adults from Africa; 2) refine and develop a female worm schistosome human challenge model; 3) identify correlates of protection, innate and adaptive immune signatures, gene expression and the role of antibodies in the prevention/control of Schistosoma infections; and 4) foster a global consortium to advance research on schistosomiasis disease burden, vaccines and address downstream access constraints in resource-poor settings. The funding requested will allow the clinical development of SchistoShield®. African site research capacity will be improved and epidemiological burden data using novel diagnostic techniques will be used to advance clinical development to Phase 2 and potential future elimination project

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium VASA (Grant agreement 815643).

UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO, Burkina Faso.

Grant for research and innovation.

EUR 259,672.78 (for the whole duration of the project).

Health research and innovation.

Improved health conditions.

Current or in progress

Five-years (since 1 June 2019).

https://cordis.europa.eu/project/rcn/223199/factsheet/en

Coordinator THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE, UK. Contact point reachable via cordis page https://cordis.europa.eu/project/id/815643

Treating hypertension (HT) and type 2 diabetes (T2D) remains a challenge for healthcare providers worldwide. Patients often receive suboptimal care, especially vulnerable groups in society. The EU-funded SCUBY project aims to reverse this trend by examining the scale up of existing evidence-based interventions for the control of both diseases in Belgium, Slovenia and Cambodia – three countries with different health systems. The project will focus on integrated care, identification of HT and/or T2D, primary care treatment, health education, self-management support and collaboration between caregivers. The aim is to analyse the organisational capacity for scaling up, and to develop and implement strategic roadmaps for each country. Lastly, the project will assess the impact of scale up on health outcomes and costs.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium SCUBY (Grant agreement 825432).

NATIONAL INSTITUTE FOR PUBLIC HEALTH, Cambodia.

Grant for research and innovation.

EUR 446,700.00 (for the whole duration of the project).

Health research and innovation.

Improved health conditions: The project will result in comprehensive scale-up strategies and increased diabetes and hypertension control in each country.

Current or in progress

Four-years (since 1 January 2019).

https://www.scuby.eu/

https://www.scuby.eu/ Coordinator: PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE, Belgium. (info@scuby.eu) Contact point reachable via cordis page: https://cordis.europa.eu/project/id/825432

Schistosomiasis is a poverty-related neglected tropical disease, impacting one billion people in 74 countries. Science ranked a schistosomiasis-vaccine as one of the top-10 vaccines urgently needed. Chemotherapy is the preferred method for schistosomiasis control; but the effectiveness of mass-treatment programs is compromised by reinfection requiring regular re-treatment. An efficacious vaccine, with long-lasting protection against all schistosomiasis forms, would impact disease control. We request funding for the clinical development of our SchistoShield®-vaccine (Sm- p80 antigen+GLA-SE adjuvant) in Burkina Faso and Madagascar, where Schistosoma mansoni (causing intestinal/ hepatic schistosomiasis) and S. haematobium (causing urinary schistosomiasis) are endemic. In baboon studies, SchistoShield® has been effective against all major schistosome species. It is the only vaccine candidate having consistently exhibited potent prophylactic, anti-fecundity, egg-induced pathology resolving, transmission-blocking and therapeutic efficacy. The objectives are to 1) assess the safety/immunogenicity of SchistoShield® in a Phase I clinical study in healthy adults from Africa; 2) refine and develop a female worm schistosome human challenge model; 3) identify correlates of protection, innate and adaptive immune signatures, gene expression and the role of antibodies in the prevention/control of Schistosoma infections; and 4) foster a global consortium to advance research on schistosomiasis disease burden, vaccines and address downstream access constraints in resource-poor settings. The funding requested will allow the clinical development of SchistoShield®. African site research capacity will be improved and epidemiological burden data using novel diagnostic techniques will be used to advance clinical development to Phase 2 and potential future elimination project.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium VASA (Grant agreement 815643).

UNIVERSITY OF ANTANANARIVO, Madagascar.

Grant for research and innovation.

EUR 864,420.38 (for the whole duration of the project).

Health related technology

Improved health conditions.

Current or in progress

Five-years (since 1 June 2019).

https://cordis.europa.eu/project/rcn/223199/factsheet/en

Coordinator THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE, UK. Contact point reachable via Cordis Page https://cordis.europa.eu/project/id/815643

VHFMoDRAD will develop and deliver rapid and point-of-care multiplex diagnostic tool(s) that will significantly increase our capacity to handle outbreaks with Filoviruses and other viral haemorrhagic fever diseases in Africa. The major expected results are the development of innovative and novel diagnostic tools for VHF diseases and the reinforcement of capacity building. VHFMoDRAD will also put in place a strong capacity building programme in West Africa. The project will disseminate widely all results as they become available, notably to public health bodies and non-governmental organisations (NGOs), via a strong outreach programme.

Innovative Medicines Initiative, Horizon 2020 programme.

Consortium VHFMoDRAD (Grant agreement number 823666).

INSTITUT PASTEUR DE DAKAR.

Grant for research and innovation.

EUR 146,250.00 (for the whole duration of the project).

Health research and innovation.

Better, faster diagnosis of viral haemorrhagic fevers like Ebola.

Current or in progress

Four-years (since 1 January 2019).

https://vhfmodrad.eu/

Coordinator INSTITUT PASTEUR, France. Contact point reachable via Cordis page https://cordis.europa.eu/project/id/825671

The goal of our European project Sonar-Global is to build a sustainable international network to strengthen the active participation of the social sciences in the prevention and response to infectious threats, including those posed by antimicrobial resistance (AMR) and vaccine hesitancy. Our activities will foster complementarities and synergies among social scientists and other stakeholders. Partnering with major international and regional institutions, it will lead activities through a program that builds governance from the ground up. It will: Develop an open-access platform to support the SoNAR-Global activities and to share them broadly. Adapt, test, and evaluate vulnerability assessment tools on the ground and engagement models to facilitate collaboration across multiple stakeholders. Create, pilot, and evaluate curricula for training social scientists in preparedness and response to infectious threats and through curricular development and piloting social science knowledge of infectious threats among non-social sciences actors.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

SoNAR-Global Consortium (Grant agreement 825671).

CENTRE REGIONAL DE RECHERCHE ET DE FORMATION A LA PRISE EN CHARGE CLINIQUE DU VIH SIDA ET MALADIES ASSOCIEES DE DAKAR CRCF, Senegal.

Grant for research and innovation.

EUR 113,750.00 (for the whole duration of the project).

Governance and other challenges in the preparedness for and the response to infectious threats.

Preparedness and response to infectious threats.

Current or in progress

Three-years (since 1 Jan 2019).

https://www.sonar-global.eu/

Coordinator INSTITUT PASTEUR, France. Contact point reachable via Cordis page https://cordis.europa.eu/project/id/825671

Identify and address the political, ethical, administrative, regulatory, and legal (PEARL) barriers and solutions related to combining, analysing and sharing a range of datatypes and specimens across infectious disease cohorts. Develop and implement a roadmap, tools and analytic methods to reconcile, analyse and link "high density laboratory" data with synthesized clinical-epidemiological metadata from objective 2. Develop and implement a roadmap, tools and analytical methods to reconcile, analyse and link human clinical, epidemiological, and diagnostic laboratory data within and across infectious disease cohorts. Develop a local governance model and searchable portal for decentralized cataloguing of data repositories and biobanks.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium RECODID (Grant agreement 825746).

INSTITUT PASTEUR DE DAKAR, Senegal.

Grant for research and innovation.

EUR 123,250.00 (for the whole duration of the project).

Health research and innovation.

Improved health status.

Four-years (since 1 January 2019).

https://recodid.eu/

Coordinator UNIVERSITAETSKLINIKUM HEIDELBERG, Germany. Contact point reachable via Cordis Page https://cordis.europa.eu/project/id/825746

We will integrate and scale up services for diabetes and hypertension in clinics in Tanzania and Uganda, either as standalone or integrated with HIV-infection. This builds on pilot studies that the partners are conducting, funded by UK NIHR, on the prevention and management of HIV, diabetes and hypertension in Africa. The aim of INTE-AFRICA is to assess the effectiveness and feasibility of large-scale scale up. Research evidence needed by African health services to scale-up and sustain the screening and management of diabetes and hypertension in different settings will be generated. The objectives include: to re-organise primary health care services so that diabetes and hypertension can be diagnosed and treated in dedicated chronic care clinics in two large regions, one in Tanzania and in Uganda; to decentralise care from health facilities to the community in order to reduce patient load at clinics and reduce reliance on (scarce) clinical staff; to evaluate these approaches in terms of acceptability (by patients and the community), numbers of patients treated and retained in care, patient clinical outcomes (blood pressure control, blood glucose control), costs of delivering integrated care for the health service and cost-effectiveness (compared to current standard care); to use the data generated to contribute evidence to the development of clinical guidelines; to develop the sustainable partnerships needed between researchers, government policy makers, public-private partnerships on an ethos of openness and equality so as to facilitate the expansion of the scale-up nationally. The majority of individuals with either hypertension or diabetes are identified after they develop complications, which leads to their poor outcomes, and to catastrophic costs to both the health service and the patient. Scaling up services for would prevent clinical complications in patients and could result in immense cost savings for patients and the health service.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

NATIONAL INSTITUTE FOR MEDICAL RESEARCH, Tanzania.

Grant for research and innovation.

EUR 898,752.50 (for the whole duration of the project)

Health research and innovation.

Improved health conditions.

Current or in progress

Four-years (since 1 January 2019).

https://cordis.europa.eu/project/rcn/219829/factsheet/en

Coordinator LIVERPOOL SCHOOL OF TROPICAL MEDICINE, UK. Contact point reachable via Cordis page: https://cordis.europa.eu/project/id/825698

We will integrate and scale up services for diabetes and hypertension in clinics in Tanzania and Uganda, either as standalone or integrated with HIV-infection. This builds on pilot studies that the partners are conducting, funded by UK NIHR, on the prevention and management of HIV, diabetes and hypertension in Africa. The aim of INTE-AFRICA is to assess the effectiveness and feasibility of large-scale scale up. Research evidence needed by African health services to scale-up and sustain the screening and management of diabetes and hypertension in different settings will be generated. The objectives include: to re-organise primary health care services so that diabetes and hypertension can be diagnosed and treated in dedicated chronic care clinics in two large regions, one in Tanzania and in Uganda; to decentralise care from health facilities to the community in order to reduce patient load at clinics and reduce reliance on (scarce) clinical staff; to evaluate these approaches in terms of acceptability (by patients and the community), numbers of patients treated and retained in care, patient clinical outcomes (blood pressure control, blood glucose control), costs of delivering integrated care for the health service and cost-effectiveness (compared to current standard care); to use the data generated to contribute evidence to the development of clinical guidelines; to develop the sustainable partnerships needed between researchers, government policy makers, public-private partnerships on an ethos of openness and equality so as to facilitate the expansion of the scale-up nationally. The majority of individuals with either hypertension or diabetes are identified after they develop complications, which leads to their poor outcomes, and to catastrophic costs to both the health service and the patient. Scaling up services for would prevent clinical complications in patients and could result in immense cost savings for patients and the health service.

DG Research and Innovation of the European Commission, Horizon 2020 programme.

Consortium INTE-AFRICA (Grant agreement 825698).

TASO LIMITED, Uganda.

Grant for research and innovation.

EUR 481,530.00 (for the whole duration of the project).

Health research and innovation.

Improved health conditions.

Current or in progress

Four-years (since 1 January 2019).

https://cordis.europa.eu/project/rcn/219829/factsheet/en  

Coordinator LIVERPOOL SCHOOL OF TROPICAL MEDICINE, UK. Contact point reachable via Cordis page: https://cordis.europa.eu/project/id/825698

The goal of our European project Sonar-Global is to build a sustainable international network to strengthen the active participation of the social sciences in the prevention and response to infectious threats, including those posed by antimicrobial resistance (AMR) and vaccine hesitancy. Our activities will foster complementarities and synergies among social scientists and other stakeholders. Partnering with major international and regional institutions, it will lead activities through a program that builds governance from the ground up. It will: Develop an open-access platform to support the SoNAR-Global activities and to share them broadly. Adapt, test, and evaluate vulnerability assessment tools on the ground and engagement models to facilitate collaboration across multiple stakeholders. Create, pilot, and evaluate curricula for training social scientists in preparedness and response to infectious threats and through curricular development and piloting social science knowledge of infectious threats among non-social sciences actors..

DG Research and Innovation of the European Commission, Horizon 2020 programme.

SoNAR-Global Consortium (Grant agreement 825671).

MAKERERE UNIVERSITY, Uganda.

Grant for research and innovation.

EUR 93,750.00 (for the whole duration of the project).

Governance and other challenges in the preparedness for and the response to infectious threats.

Improved health status.

Current or in progress

Three-years (since 1 Jan 2019).

https://www.sonar-global.eu/

Coordinator INSTITUT PASTEUR, France. Contact point reachable via Cordis Page: https://cordis.europa.eu/project/id/825671

Improve compliance with international standards in terms of air safety and security in Zambia, with the support of European Aviation Safety Agency (EASA) and other service provider to be yet contracted (two separate but interlinked components of the same project). The programme aims to assist in the development of improved policies and an improved institutional and regulatory framework for the aviation sector (which will include aviation safety and security and gender sensitivity).

Ministry of Transport and Communications, Civil Aviation Authority, Zambia Airports Corporation Ltd and other agencies.

EUR 5.6 million.

Civil Aviation.

Capacity building for setting-up, maintaining and operating internationally compliant Management Information Systems, reporting standards, air navigation services and national security plan for airports and air traffic management; Know-how transfer necessary to produce secondary legislation and management procedures ensuring improved safety oversight in line with international requirements (ICAO); Know-how transfer for civil aviation training centres (training-of-trainers).

Current or in progress

November 2016 - November 2024.

https://www.eu-assp-z.org/

Chasiya Kazembe: ckazembe@nao.gov.zm Carols Menendez De Solas: carlos.menendez-de-solas@easa.europa.eu Natalia RUSSIMOVA: Natalia.RUSSIMOVA@easa.europa.eu

The project aims to a) promote enabling regulatory framework, renewable energy friendly policies and more effective and inclusive sector institutions; b) enhance government and private sector capacities to develop gender inclusive Renewable Energy and Energy Efficiency projects; c) improve Energy Efficiency at household and industry level by awareness raising and support to economic activities.

Ministry of Energy, Energy Regulation Board, Rural Electrification Authority, ZESCO (national utility) and other public agencies.

EUR 40 million, TA component of approx. EUR 10 million.

Energy sector.

Improved policies and planning for investments in Renewable Energy and Energy Efficiency (RE/EE), demonstration projects implemented and increased number of people getting access to energy services. Capacity building for strengthening and improvement of national institutions for improved policy making and planning for Renewable Energy and Energy Efficiency (RE/EE) deployment, as well as procurement and oversight of RE/EE projects; Know-how transfer to public and private entities on technical and economic aspects relating to RE/EE solutions/business models; Awareness raising of the society on effective and productive use of RE/EE solutions/applications; Incentives (grants) for private developers to stimulate investment in low-carbon technologies to contribute to country goals on energy access and climate change mitigation (investment component separate from TA part: EUR 25 million).

Completed

March 2018 to March 2023.

Claudio.BACIGALUPI@eeas.europa.eu

Netherlands

Effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services

European Commission, Horizon 2020

ACADEMISCH ZIEKENHUIS GRONINGEN

INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH BANGLADESH

Research and innovation project

EUR 135,750

Implementation research into cervical cancer screening and secondary prevention in different settings

Improved health conditions

Current or in progress

3 years (started on 01/02/2021)

https://cordis.europa.eu/project/id/964270

Project coordinator, ACADEMISCH ZIEKENHUIS GRONINGEN Contact point reachable via Cordis page https://cordis.europa.eu/project/id/964270

Netherlands

Effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services

European Commission, Horizon 2020

ACADEMISCH ZIEKENHUIS GRONINGEN

FRIENDSHIP

Research and innovation project

EUR 239,375

Implementation research into cervical cancer screening and secondary prevention in different settings

Improved health conditions

Current or in progress

3 years (started on 01-02-2021)

https://cordis.europa.eu/project/id/964270

Project coordinator, ACADEMISCH ZIEKENHUIS GRONINGEN Contact point reachable via Cordis page https://cordis.europa.eu/project/id/964270

Netherlands

Effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services

European Commission, Horizon 2020

ACADEMISCH ZIEKENHUIS GRONINGEN

UGANDA RURAL DEVELOPMENT AND TRAINING PROGRAMME

Research and innovation project

EUR 243,437,5

Implementation research into cervical cancer screening and secondary prevention in different settings

Improved health conditions

Current or in progress

3 years (started on 01.02.2021)

https://cordis.europa.eu/project/id/964270

Project coordinator, ACADEMISCH ZIEKENHUIS GRONINGEN Contact point reachable via Cordis page https://cordis.europa.eu/project/id/964270

Netherlands

Effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services

European Commission, Horizon 2020

ACADEMISCH ZIEKENHUIS GRONINGEN

UGANDA CANCER INSTITUTE

Research and innovation project

EUR 79,000

Implementation research into cervical cancer screening and secondary prevention in different settings

Improved health conditions

Current or in progress

3 years (started on 01.02.2021)

https://cordis.europa.eu/project/id/964270

Project coordinator, ACADEMISCH ZIEKENHUIS GRONINGEN Contact point reachable via Cordis page https://cordis.europa.eu/project/id/964270

Spain

The EU-Africa PerMed project has the final objective of integrating African countries into ICPerMed activities as a means to contribute to the implementation of Personalised Medicine (PM) in the global context, fostering joint PM projects and programmes between Europe and Africa

European Commission, Horizon 2020

SOCIEDAD PARA EL FOMENTO DE LA INNOVACIÓN TECNOLÓGICA S.L. - INNOVATEC

EAST CENTRAL AND SOUTHERN AFRICA HEALTH COMMUNITY

Research and innovation project

EUR 133,475

Strengthening bilateral EU-AU science, technology and innovation in health

Improved health conditions

Current or in progress

4 years (starting date 01/02/2021)

https://cordis.europa.eu/project/id/964333

Project coordinator, SOCIEDAD PARA EL FOMENTO DE LA INNOVACIÓN TECNOLÓGICA S.L. - INNOVATEC, Spain Contact point reachable via Cordis page https://cordis.europa.eu/project/id/964333

BETTEReHEALTH will set up four Regional Hubs based in Tunisia, Ghana, Ethiopia and Malawi, already endorsed by each country's Ministry of Health. Each hub will organise coordination and networking activities (including two regional workshops) involving national and regional actors. We are planning actions to address three aspects related to successful e-health: human, technical and public policy factors. We will also organise two international workshops to promote the cooperation and networking between Europe and Africa. BETTEReHEALTH will create open access registries by collecting information from African countries regarding e-health policies and existing e-health solutions. The registries will be used to identify best-practices and produce useful knowledge regarding e-health implementation. The knowledge produced in registries, together with the input from the other activities will be synthesized into e-health policy roadmaps and strategic implementation plans for better e-health services for the four countries hosting Regional Hubs, but will also be of high relevance for other African countries. The strengths of BETTEReHEALTH are the diversity of the involved partners, which will contribute to an interdisciplinary approach (including health, technical and policymaking actors), the evidence-based approach guaranteed by the academic and research partners, and the strong local involvement ensured by the four Regional Hubs. BETTEReHEALTH will increase the level of international cooperation in e-health, inform and strengthen end-user communities and policy makers in making the right decisions for the successful implementation of e-health, and lead to increased opportunities for stakeholders in Africa and Europe with the overall aim of better health outcomes through better healthcare accessibility and higher quality.

European Commission, Horizon 2020

SINTEF AS

HEALTH INFORMATION SYSTEMS PROGRAMMES LIMITED

Research and innovation project

EUR 157,575

Successful implementation of e-health services

Improved health conditions

Current or in progress

2 years (starting date 01.01.2021)

https://cordis.europa.eu/project/id/101017450

Project coordinator, SINTEF AS, Norway Contact point reachable via Cordis Page https://cordis.europa.eu/project/id/101017450